Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: GOG 130F Principal Investigator: Mutch, David
Title: A Phase II Evaluation of Ixabepilone (IND #710428) in the Treatment of Recurrent or Persistent Carcinosarcoma of the Uterus (NCI version 11/29/10)
Phase: II Disease Site: Corpus Uteri
Participating Site(s):
 
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to find out if the study drug, Ixabepilone, works in treating your type of cancer and to find out what side effects are caused by treatment with this drug.
 
More Information:
Internal Protocol Documents (requires Siteman administrative database password)